Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE (see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY). Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1363)
Biomarker and diagnostic research for sciatic neuropathy has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
196 publications have been identified in PubMed for sciatic neuropathy. Research spans Basic Science / Preclinical (36%), Case Report / Case Series (18%), and Clinical Trial Publication (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 71 | 36% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:53 PM UTC
Patient case studies |
36 |
18% |
Clinical study results | 29 | 15% |
Disease patterns and progression | 21 | 11% |
Research summaries | 19 | 10% |
Testing and diagnosis research | 15 | 8% |
Other research | 3 | 2% |
New treatment approaches | 2 | 1% |
Ipponi E (2026). [PMID: 41879535](https://pubmed.ncbi.nlm.nih.gov/41879535/). *Folia Med (Plovdiv)*. [Case Report / Case Series]
Fu YS (2026). [PMID: 40016058](https://pubmed.ncbi.nlm.nih.gov/40016058/). *J Formos Med Assoc*. [Clinical Trial Publication]
Wu WT (2026). [PMID: 42279537](https://pubmed.ncbi.nlm.nih.gov/42279537/). *Diagnostics (Basel)*. [Case Report / Case Series]
Alqhtani AN (2026). [PMID: 41569285](https://pubmed.ncbi.nlm.nih.gov/41569285/). *Physiol Int*. [Basic Science / Preclinical]
Shim SW (2026). [PMID: 41553142](https://pubmed.ncbi.nlm.nih.gov/41553142/). *Pain*. [Basic Science / Preclinical]
Sousa FSS (2026). [PMID: 41765235](https://pubmed.ncbi.nlm.nih.gov/41765235/). *Behav Brain Res*. [Basic Science / Preclinical]
Badr IT (2026). [PMID: 41505508](https://pubmed.ncbi.nlm.nih.gov/41505508/). *JBJS case connector*. [Case Report / Case Series]
Muthuraman A (2026). [PMID: 42153193](https://pubmed.ncbi.nlm.nih.gov/42153193/). *Iran J Pharm Res*. [Basic Science / Preclinical]
Tekin S (2026). [PMID: 41905502](https://pubmed.ncbi.nlm.nih.gov/41905502/). *Neurotoxicology*. [Basic Science / Preclinical]
Kondratyev VP (2026). [PMID: 42179124](https://pubmed.ncbi.nlm.nih.gov/42179124/). *Zh Vopr Neirokhir Im N N Burdenko*. [Clinical Trial Publication]